XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
SideSwap Reopens Liquid Markets; L-BTC Redemptions Still Paused
SideSwap says its Liquid markets reopened on September 10, 2026, after Liquid resumed block production, but L-BTC redemptions into Bitcoin remain suspended whil...
US House Panel Sets Sept. 16 Crypto Tax Rules Markup
The US House Ways and Means Committee has reportedly set a September 16 markup for crypto tax rules, though no official notice confirms the date. What is docume...
U.S. Bank Tests USBDC Cross-Border Transfers on Stellar
The named asset in the test is USBDC, and the named settlement rail is the public Stellar network . The trial evaluates whether the bank can move that stablecoi...
Kalshi Seeks US Approval for Single-Stock Perpetual Futures
Kalshi is seeking US approval for single-stock perpetual futures tied to Tesla, Apple, and Nvidia, extending the prediction-market operator’s push into perpetua...
Cantor Doubles Bitmine Price Target to $63.60
Cantor Fitzgerald has doubled its Bitmine price target to $63. 60, framing the company’s Ethereum treasury strategy as a maturing investment proposition, the ne...
Circle’s EURC Goes Live on Upbit in South Korea
The report identifies three things: the asset is EURC, the platform is Upbit, and the market is South Korea. A single source, Crypto Briefing, reported the list...
